0001127602-24-017571.txt : 20240604 0001127602-24-017571.hdr.sgml : 20240604 20240604141521 ACCESSION NUMBER: 0001127602-24-017571 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240531 FILED AS OF DATE: 20240604 DATE AS OF CHANGE: 20240604 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LAVIZZO-MOUREY RISA J CENTRAL INDEX KEY: 0001034465 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 241017149 MAIL ADDRESS: STREET 1: GE HEALTHCARE TECHNOLOGIES INC. STREET 2: 500 W. MONROE ST. CITY: CHICAGO STATE: IL ZIP: 60661 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL ROAD CITY: KENILWORTH STATE: NJ ZIP: 07033 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-05-31 0000310158 Merck & Co., Inc. MRK 0001034465 LAVIZZO-MOUREY RISA J MERCK & CO., INC. 126 EAST LINCOLN AVENUE RAHWAY NJ 07065 1 0 Common Stock 1000 D Phantom Stock 2024-05-31 4 A 0 1752.4295 125.54 A Common Stock 1752.4295 12120.4279 D 1-for-1 Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation. Holdings include shares acquired in dividend reinvestment transactions. /s/ Kelly E. W. Grez as Attorney-in-Fact for Risa Lavizzo-Mourey 2024-06-04